Table of Contents EMEA (Europe, Middle East and Africa) Peripheral Arterial Disease (PAD) Therapeutics Market Report 2018 1 Peripheral Arterial Disease (PAD) Therapeutics Overview 1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Therapeutics 1.2 Classification of Peripheral Arterial Disease (PAD) Therapeutics 1.2.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Anti-Platelet Drugs 1.2.4 Dual Antiplatelet Therapy Drugs 1.2.5 Others 1.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market by Application/End Users 1.3.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market by Region 1.4.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of Peripheral Arterial Disease (PAD) Therapeutics (2013-2025) 1.5.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2025) 1.5.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2013-2025) 2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Competition by Players/Manufacturers 2.1.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Share by Players (2013-2018) 2.1.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sale Price by Players (2013-2018) 2.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics (Volume and Value) by Type/Product Category 2.2.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type (2013-2018) 2.2.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sale Price by Type (2013-2018) 2.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics (Volume) by Application 2.4 EMEA Peripheral Arterial Disease (PAD) Therapeutics (Volume and Value) by Region 2.4.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Region (2013-2018) 2.4.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Price by Region (2013-2018) 3 Europe Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2013-2018) 3.1.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2013-2018) 3.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type 3.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Application 3.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Countries (2013-2018) 3.4.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue by Countries (2013-2018) 3.4.3 Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 3.4.4 France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 3.4.5 UK Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 3.4.6 Russia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 3.4.7 Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 3.4.8 Benelux Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 4 Middle East Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2013-2018) 4.1.1 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2013-2018) 4.2 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type 4.3 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Application 4.4 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Countries (2013-2018) 4.4.2 Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 4.4.4 Israel Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 4.4.5 UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 4.4.6 Iran Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 5 Africa Peripheral Arterial Disease (PAD) Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Value (2013-2018) 5.1.1 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2013-2018) 5.2 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type 5.3 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Application 5.4 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Countries (2013-2018) 5.4.2 Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue by Countries (2013-2018) 5.4.3 South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 5.4.4 Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 5.4.5 Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 5.4.6 Algeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2013-2018) 6 EMEA Peripheral Arterial Disease (PAD) Therapeutics Manufacturers/Players Profiles and Sales Data 6.1 AstraZeneca Plc. (UK) 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Bayer HealthCare Pharmaceuticals (Germany) 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Bristol-Myers Squibb Company (US) 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Merck & Co., Inc. (US) 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Proteon Therapeutics, Inc. (US) 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Sanofi S.A. (France) 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Symic Bio, Inc. (US) 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 TheraVasc Inc. (US) 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 AnGes MG, Inc. (Japan) 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Athersys, Inc. (US) 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Peripheral Arterial Disease (PAD) Therapeutics Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Betagenon AB (Sweden) 6.12 miRagen Therapeutics, Inc. (US) 6.13 Multi Gene Vascular Systems Ltd (Israel) 6.14 ViroMed Co. Ltd. (Korea) 7 Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Cost Analysis 7.1 Peripheral Arterial Disease (PAD) Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Forecast (2018-2025) 11.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA Peripheral Arterial Disease (PAD) Therapeutics Price and Trend Forecast (2018-2025) 11.2 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2018-2025) 11.7 EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Peripheral Arterial Disease (PAD) Therapeutics Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) by Type (2013-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Market Share by Type (Product Category) in 2017 Figure Anti-Platelet Drugs Product Picture Figure Dual Antiplatelet Therapy Drugs Product Picture Figure Others Product Picture Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) by Application (2013-2025) Figure EMEA Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Application in 2017 Figure Hospitals Examples Table Key Downstream Customer in Hospitals Figure Clinics Examples Table Key Downstream Customer in Clinics Figure Others Examples Table Key Downstream Customer in Others Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Region (2013-2025) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Status and Forecast by Countries Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Status and Forecast by Countries Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Status and Forecast by Countries Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Growth Rate (2013-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Major Players Product Sales Volume (K Units) (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) of Major Players (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players (2013-2018) Figure 2017 Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players Figure 2017 Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) by Players (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players (2013-2018) Table 2017 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players Table 2017 EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sale Price (USD/Unit) by Players (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Market Share by Type (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Type (2013-2018) Figure Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2013-2018) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Type (2013-2018) Figure Revenue Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2017 Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sale Price (USD/Unit) by Type (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Market Share by Application (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Application (2013-2018) Figure Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Application (2013-2018) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2017 Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Market Share by Region (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Region (2013-2018) Figure Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Region (2013-2018) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in 2017 Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Region (2013-2018) Figure Revenue Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Region (2013-2018) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share Regions in 2017 Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit) by Region (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2013-2018) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2013-2018) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type in 2017 Table Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2013-2018) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2017 Table Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Countries (2013-2018) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries in 2017 Table Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) by Countries (2013-2018) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries in 2017 Figure Germany Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure France Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure UK Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Russia Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Italy Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Benelux Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Applications (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Market Share by Applications (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2017 Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) by Countries (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Market Share by Countries (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Market Share by Countries in 2017 Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) by Countries (2013-2018) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Israel Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure UAE Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Iran Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type in 2017 Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) by Countries (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Countries in 2017 Table Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) by Countries (2013-2018) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries (2013-2018) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Countries in 2017 Figure South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Algeria Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2013-2018) Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in EMEA (2013-2018) Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in EMEA (2013-2018) Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Peripheral Arterial Disease (PAD) Therapeutics Figure Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics Figure Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis Table Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2017 Table Major Buyers of Peripheral Arterial Disease (PAD) Therapeutics Table Distributors/Traders List Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate Forecast (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) and Trend Forecast (2018-2025) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Region (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Region (2018-2025) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share Forecast by Region (2018-2025) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Countries (2018-2025) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Countries (2018-2025) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share Forecast by Countries (2018-2025) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Countries (2018-2025) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Countries (2018-2025) Table Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share Forecast by Countries (2018-2025) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Countries (2018-2025) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Countries (2018-2025) Table Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share Forecast by Countries (2018-2025) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Type (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2018-2025) Table EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2018-2025) Figure EMEA Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources